Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Clin Pharmacol ; 85(1): 240-244, 2019 01.
Article in English | MEDLINE | ID: mdl-30328132

ABSTRACT

Insomnia is a frequent symptom in depressed patients. It can present with difficulty in initiating and/or maintaining sleep. We retrospectively evaluated a group of 15 patients affected by major depressive disorder and complaining of insomnia, who started vortioxetine (VOR) treatment for their depressive symptoms. The following questionnaires were captured at baseline and follow-up: Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale and Beck Depression Inventory. Pittsburgh Sleep Quality Index total score significantly decreased between follow-up and baseline (P < 0.01), and in several subitems related to sleep quality and continuity. Moreover, Epworth Sleepiness Scale decreased between follow-up and baseline (P < 0.01). Finally, Beck Depression Inventory reduction was also evident between follow-up and baseline (P < 0.01). This retrospective analysis showing the significant effect of VOR on both depressive symptoms and insomnia in patients showing comorbid major depressive disorder and insomnia invites further research in order to confirm this preliminary evidence. We hypothesize that the VOR mechanism of action may explain the improvement of subjective sleep, other than depressive symptoms.


Subject(s)
Antidepressive Agents/pharmacology , Depressive Disorder, Major/drug therapy , Sleep Initiation and Maintenance Disorders/drug therapy , Sleep/drug effects , Vortioxetine/pharmacology , Adult , Antidepressive Agents/therapeutic use , Depressive Disorder, Major/complications , Depressive Disorder, Major/diagnosis , Female , Follow-Up Studies , Humans , Male , Middle Aged , Psychiatric Status Rating Scales , Retrospective Studies , Severity of Illness Index , Sleep Initiation and Maintenance Disorders/diagnosis , Sleep Initiation and Maintenance Disorders/etiology , Surveys and Questionnaires/statistics & numerical data , Vortioxetine/therapeutic use
2.
Chem Commun (Camb) ; 52(43): 6977-80, 2016 May 19.
Article in English | MEDLINE | ID: mdl-27063187

ABSTRACT

A thiophene-based donor-acceptor phenothiazine dye has been functionalized with a peripheral glucose unit (PTZ-GLU) to bust its affinity to water and enhance dye-sensitized photogeneration of hydrogen. Compared to the corresponding alkyl derivative (PTZ-ALK), as well as the common hydrophilic triethylene glycol substitution (PTZ-TEG), the sugar derivative shows a lower contact angle; PTZ-GLU performed twice more efficient than PTZ-TEG in the photogeneration of hydrogen in terms of evolved gas and turnover number.


Subject(s)
Coloring Agents/chemistry , Glucosides/chemistry , Hydrogen/chemistry , Phenothiazines/chemistry , Catalysis , Coloring Agents/chemical synthesis , Glucosides/chemical synthesis , Light , Nanocomposites/chemistry , Phenothiazines/chemical synthesis , Platinum/chemistry , Titanium/chemistry , Water/chemistry , Wettability
SELECTION OF CITATIONS
SEARCH DETAIL
...